Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid

Journal of Infectious Diseases

Volumn 182, Issue 5, 2000, Pages 1326-1330

  Prince, Gregory A ^a   Mathews, Amy ^a   Curtis, Spencer J ^a   Porter, David D ^b  

^a Virion Systems Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MONOCLONAL ANTIBODY; PALIVIZUMAB; TRIAMCINOLONE ACETONIDE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT OUTCOME; VIRUS INFECTIVITY; VIRUS PNEUMONIA;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BRONCHIOLITIS; DISEASE MODELS, ANIMAL; HESPEROMYINAE; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRIAMCINOLONE ACETONIDE;

EID: 0033787444     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315894     Document Type: Article

References (21)

1. Respiratory syncytial virus
2. Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden
3. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation
4. Respiratory syncytial virus vaccines
5. Respiratory syncytial virus infection: Immune response, immunopathogenesis, and treatment
6. Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection
7. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat
8. In vivo inhibition of respiratory syncytial virus by ribavirin
9. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children
10. Clinical experience with aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants
11. Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants
12. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections
13. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children
14. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein
15. Influence of immunological factors in respiratory syncytial virus disease of the lower respiratory tract
16. Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid
17. Stabilization of respiratory syncytial virus (RSV) against thermal inactivation and freeze-thaw cycles for development and control of RSV vaccines and immune globulin
18. The pathogenesis of respiratory syncytial virus infection in cotton rats
19. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus
20. Respiratory syncytial virus antiviral agents